F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first ever FDA-approved medication for treating obstructive sleep apnea, particularly aimed at those with obesity.
Here's how Eli Lilly is fixing its Zepbound supply shortage
Eli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.
Weight-Loss Drugs Help Sleep Apnea Symptoms
Zepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.
Eli Lilly raises price of Zepbound while trumpeting discount on starter vials
Eli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.
Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?
Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.
F.D.A. Approves Weight-Loss Drug to Treat Sleep Apnea
Zepbound is the first ever FDA-approved medication for treating obstructive sleep apnea, particularly aimed at those with obesity.
Here's how Eli Lilly is fixing its Zepbound supply shortage
Eli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.
Weight-Loss Drugs Help Sleep Apnea Symptoms
Zepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.
Eli Lilly raises price of Zepbound while trumpeting discount on starter vials
Eli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.
Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?
Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.
The death of nurse Susan McGowan has raised concerns over the safety of the weight-loss drug Mounjaro, linked to her unexpected health decline.
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
BioAge Labs is entering the public market with its obesity drug Azelaprag in clinical trials, aiming for significant growth and competition in the weight loss sector.
Users of New Weight Loss Drug Had Lower Blood Pressure in Study
Tirzepatide, a weight loss drug, was found to significantly lower blood pressures after 36 weeks of use.
The study assessed tirzepatide's effects on weight loss and found that participants taking the drug had lower blood pressures when measured with a 24-hour monitor.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.